Including data for more than 125,000 compounds and biological agents, a dataset leverages a variety of sources including trial registries, news and stock prices and artificial intelligence to annotate outcomes and features automatically, as a resource to inform drug development from an organizational perspective and identify features that could be predictive of trial success.
- Chufan Gao
- Jathurshan Pradeepkumar
- Jimeng Sun